Search Results for: universal cells

Weekly reads: BioViva & life-extension clinic, RMATs, universal cells

BioViva CEO Liz Parrish in YouTube video.

I’ve written before about Liz Parrish and her life-extension firm BioViva. Now they appear to have connections with another entity called Integrated Health Systems or IHS, according to a new Wired article. Some of what is going on with IHS and maybe BioViva in Mexico seems extremely risky to me. BioViva, Parrish, and Integrated Health Systems The […]

Weekly reads: BioViva & life-extension clinic, RMATs, universal cells Read More »

Clade Therapeutics pursues universal cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

Clade  Therapeutics has been pursuing the idea of using gene-editing to make universally compatible cells. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients without fear of immune rejection? Clade Therapeutics Boston Business Journal covers the

Clade Therapeutics pursues universal cells for cancer therapy Read More »

Weekly reads: More good news on stem cells for diabetes, Panda stem cells, pricey longevity club

stem cell therapy for diabetes

People often ask me what is the most promising new cell therapy and while it is difficult to choose just one, I often highlight the promise of stem cells for diabetes. Here in the U.S., early data from diabetes clinical trials by Vertex look encouraging. Other teams worldwide are also working in this space and

Weekly reads: More good news on stem cells for diabetes, Panda stem cells, pricey longevity club Read More »

Weekly reads: bat stem cells & viruses, Lineage Cell, He Jiankui visa

bat stem cells, stem cells

Occasionally when I write a post there is an angry reaction to it in the blog comments, which was the case for my recent fact-check of the LifeWave X39 patches.  As you can see in that post, I didn’t find convincing data to either back up the claimed stem cell connection. In my opinion, there

Weekly reads: bat stem cells & viruses, Lineage Cell, He Jiankui visa Read More »

New research on CRISPR gene-editing in stem cells, infographic

CRISPR-infographic-stem-cells_small

As a pivotal advance in the gene-editing field and timeline, CRISPR continues to be utilized for research on stem cells and human diseases. Today, I will explain some of the most notable recent findings in the stem cell-CRISPR field. To start things off, I have also created an infographic that briefly explains what CRISPR-Cas9 is,

New research on CRISPR gene-editing in stem cells, infographic Read More »

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs

Reprogramming-roadmap-reveals-route-to-human-induced-trophoblast-stem-cells

Reading to them was one of my favorite things to do with my kids when they were little, but it’s a long way from Goodnight Moon to this week’s list of recommended reads, although “bee brain” may have got their attention. Please take a minute to complete our The Niche reader survey for a chance

Recommended reads: Bee brain, COVID, from Russia with stem cells, pubs Read More »

Yamanaka on making iPS cells from each patient: ‘in reality, we cannot do that’

One of the big issues related to using induced pluripotent stem (iPS) cells is cost. To make iPS cells from each patient for subsequent stem cell-based treatment would cost a fortune, by some estimates $200,000 or more per patient if done one-by-one. It could easily end up not being covered by insurances companies and Medicare,

Yamanaka on making iPS cells from each patient: ‘in reality, we cannot do that’ Read More »

The New Scientist goes after ES cells with strange opinion piece

What the heck happened to The New Scientist? An anti-embryonic stem cell piece they just recently published was an exercise in weird, moral obfuscation. Quite a few scientists and policy makers are fairly regular readers of The New Scientist. They might start reconsidering how they want to spend that $99/year. Why not use it to

The New Scientist goes after ES cells with strange opinion piece Read More »